Majmudar & Partners represented Otsuka Pharmaceutical Factory, Inc, a leading Japanese pharmaceuticals manufacturing company, in respect of the proposed acquisition of an additional 20% stake in its existing joint venture company, Otsuka Pharmaceutical India Private Limited, from its joint venture partner, Claris Lifesciences Limited, for US$20 million. The proposed acquisition is subject to approval of the Foreign Investment Promotion Board.

Rukshad Davar, Partner, led the team from Majmudar & Partners on this transaction. Veritas Legal represented Claris Lifesciences Limited.